New Paradigm of Innovation: Tata Passenger Electric Mobility Proudly Showcases Its New Vision, a Concept Built on Its Pure EV Architecture
Taking a giant stride towards the next generation of electric vehicles, Tata Passenger Electric Mobility (TPEM) today made a smashing debut with the global unveil of the AVINYA Concept – an expression of the Company’s vision of a pure electric vehicle, based on its GEN 3 architecture. Derived from the Sanskrit language, the name AVINYA stands for ‘Innovation’. The AVINYA Concept introduces a new typology of mobility that liberates enormous roominess and comfort, not restricted by traditional segmentation. It comes packed with new age technology, software and Artificial Intelligence that work in the background to deliver wellness and tranquillity during transit. Providing an extremely premium yet simple and calming customer experience, this concept will be fairly accessible to a majority of customers of fast growing, high volume segments of today. With this, TPEM is all set to unleash a new breed of EVs that will redefine the automobile space. This path breaking EV will be introduced to the market by 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220429005300/en/
Tata Passenger Electric Mobility (TPEM) today made a smashing debut with the global unveil of the AVINYA Concept – an expression of the Company’s vision of a Pure Electric Vehicle, based on its GEN 3 architecture. A vision pivotal in signalling a ‘New Paradigm’, this concept reflects the Company’s new identity, an identity which is here to challenge the status quo. All set to be introduced to the market by 2025, the AVINYA Concept will give rise to a new breed of EVs. In the image, (L-R) Mr. Anand Kulkarni, Vice President, Product Line & Operations, Tata Passenger Electric Mobility Ltd., Mr. Vivek B Srivatsa, Head, Marketing, Sales and Service Strategy, Tata Passenger Electric Mobility Ltd., Mr. Martin Uhlarik, Head of Design, Tata Motors, Mr. N Chandrasekaran, Chairman, Tata Sons and Tata Motors and Mr. Shailesh Chandra, Managing Director, Tata Motors Passenger Vehicles Ltd. and Tata Passenger Electric Mobility Ltd., along with the stunning AVINYA. (Photo: Business Wire)
Speaking at this landmark occasion, Mr. N Chandrasekaran, Chairman, Tata Sons and Tata Motors said,“While making the AVINYA Concept a reality, the central idea was to offer a mobility solution like no other – a state of the art software on wheels that is well designed, sustainable and reduces the planet’s carbon footprint. Green Mobility is at the nucleus of TPEM, and the AVINYA Concept is the perfect reflection of what the company stands for – a creation that will not only accelerate the adoption of EVs but also lead this movement. Furthermore, at the Tata group, we are uniquely positioned to bring all the expertise that is necessary to build these mobility solutions and we are confident that in years to come we will make a larger and sustainable impact not only in India but globally as well.”
Adding to this, Mr. Shailesh Chandra,Managing Director, Tata Motors Passenger Vehicles Ltd., and Tata Passenger Electric Mobility Ltd. said, “It is indeed a matter of pride for us at TPEM to present the AVINYA Concept to the world, a vision pivotal in signalling a ‘New Paradigm’. Holding on to its values of Simplicity, Timelessness, Effortlessness and Grace, the AVINYA is not only a concept but is our new identity, an identity which is here to challenge the status quo. It gives me an intense sense of optimism to present a new typology of vehicles that will introduce the automobile industry to options beyond mobility – a tranquil space which will offer you a complete sensory experience while on the move. At its heart, the AVINYA Concept has ‘IN’, which demonstrates our Indian roots and highlights how we pride ourselves in discovering new ways to move and power vehicles. The AVINYA Concept is the fruition of our first idea built on our Pure EV GEN 3 architecture, enabling us to produce a range of globally competitive EVs. Our vision for pure EVs is focused on delivering wellness and rejuvenation while traveling, backed by cutting-edge technologies, aimed at improving the overall quality of life.”
A TIMELESS DESIGN:
Originally inspired by a catamaran, the AVINYA Concept is an uncompromising vision for electric mobility. With a new silhouette, this concept is a mixology of the best of the worlds – it a product which combines the essence of a premium hatch to the luxuries and versatility of an SUV and the roominess and functionality of an MPV – all put together to create something new and beautiful. A significant highlight on the front and the rear of the vehicle is the new identity. This new identity as a part of the DRL is a subtle nod to our commitment to enhance the quality of life and is a pivotal step in the evolution of EVs. It is also the manifesto and emphasises the Horizon and the Infinite possibilities that the Gen 3 electrification will offer. Gliding to the sides, one is met by the ‘Butterfly’ doors, which welcome you with open arms to a class leading spacious interior which is sure to make its inmates feel calm.
The AVINYA Concept focuses on a human centric design and promises a sensory journey of its own. From the skydome that enhances the overall sense of space and natural light to the functional console inspired steering wheel, to the voice activated systems for a deeper interface for all its passengers, to the sustainable materials being used, that communicate the ethos of the product and finally the finishing touch of the aroma diffuser – that envelopes you in an ambience that is serene and soothing.
Furthermore, envisaging a future trend, this concept is designed to believe that lesser screen time is the way to go. Taking this into consideration the AVINYA Concept has been made screen-less, to bar any distractions inside the car and create a stress free environment for the mind and soul.
A PURE EV AT ITS CORE:
The AVINYA Concept stands for empathetic mobility, a machine that is engineered to be smart, spacious, sustainable yet techy. The agile and robust Pure EV GEN 3 Architecture offers this concept with a flexible design while boasting of next generation connectivity, advanced driver assistance systems and enhanced performance and efficiency. Pioneered out of India for the world, this global platform offers high structural safety and has the next level of water proofing and dust protection, making it ready for all forms of terrains.
This architecture is built with the use of next-gen materials, efficient electronic componentry and proprietary energy management strategies & algorithms for efficiency management. Use of light-weight materials, and optimized structure for an EV only powertrain with enabled appropriate stiffness, helps minimize the overall mass, leading to good weight management. Furthermore, the battery used will support an ultra-fast charge capability, in line with the infrastructure evolution, pumping a minimum 500 kms range in under 30 minutes. The overall philosophy for enhanced range would be ‘Minimize- Maximize – Optimize’.
Drawing inspiration from human sensory cues whilst promising a stress-free experience with every drive, the AVINYA stands by the concept of minimalism and is a leap forward in the right direction, making it the absolute regiment of sustainable movement.
To know more about this impressive Concept, kindly refer to the detailed concept note.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda and Seagen to Highlight ADCETRIS ® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma26.5.2022 23:25:00 CEST | Press release
Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., (NASDAQ:SGEN) today announced that overall survival (OS) data from the Phase 3 ECHELON-1 clinical trial of an ADCETRIS® (brentuximab vedotin) plus chemotherapy combination will be presented in an oral session at the 59th American Society of Clinical Oncology (ASCO) Annual Meeting on Friday, June 3, 2022, 1:00-4:00 PM CT, and at the 27th European Hematology Association (EHA) Annual Meeting on Friday, June 10, 2022, 11:30 – 12:45 CEST. “The longer-term follow-up data from the ECHELON-1 trial have significant clinical importance, as this trial represents one of only two frontline randomized studies in advanced stage Hodgkin lymphoma that shows an overall survival advantage for the experimental arm,” said Stephen Ansell, M.D., Ph.D., Mayo Clinic, and ECHELON-1 study investigator. “These results clearly show that the addition of brentuximab vedotin to chemotherapy improves the long-term outcome of patients and the combination
Ipsen: ASCO 2022: New Cabometyx ® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer26.5.2022 23:00:00 CEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced encouraging data to be presented for the multi-targeted tyrosine kinase inhibitor (TKI), Cabometyx® (cabozantinib), across a range of cancer types at this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2022) to be held on 3-7 June. Data presentations will include findings in metastatic non-small cell lung cancer (NSCLC), as well as established indications of advanced renal cell carcinoma and radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). These data show that the therapeutic potential of Cabometyx as a key treatment option in a broad range of tumors is continuing to be realized. Updated outcomes from the multicenter Phase Ib COSMIC-021 trial evaluating the combination of Cabometyx plus atezolizumab in an expanded patient population in metastatic NSCLC demonstrate encouraging clinical activity with manageable toxicity in people previously treated with an immune checkpoint inhib
New Better Dispensing Videos from Nordson EFD Explain Jetting Technology and How to Choose the Right Solution26.5.2022 19:00:00 CEST | Press release
Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces a new Better Dispensing™ How-To Video series. These three highly educational videos presented by EFD application specialist, Tom Muccino, provide best practices for choosing between contact dispensing and non-contact (jet) dispensing, and how to select the best jetting valve for a manufacturing application. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510006079/en/ xQR41 Series MicroDot™ needle valve (left) and PICO Pµlse XP jet valve (right). (Photo: Business Wire) “One of the main differences is that with jetting, your valve never touches the surface of the part. Instead, your fluid “flies” or “jets” out of the valve, which is above the part,” Muccino explains in the first video. “This makes jetting perfect for fragile or complex parts.” Nordson EFD provides a wide range of contact and non-contact (jet
Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA26.5.2022 18:17:00 CEST | Press release
On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio). “Partnering with Deebio in June 2021 was a huge milestone for the pharmaceutical compounding industry as it allowed us to secure and stabilize the supply of high quality Thyroid Powder for the US market,” said Panagiota Danopoulos, Senior Vice President of Global Strategy & Innovation at Medisca. “After going to market, we immediately realized that the demand for Thyroid Powder extended outside of our usual distribution channels to compounding pharmacies,” continued Danopoulos. “And we had the capacity to upscale supply to make this critical ingredient accessible to various markets, chan
Merck to Present Latest Research From Oncology Portfolio at ASCO 202226.5.2022 18:00:00 CEST | Press release
Merck, a leading science and technology company, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7, 2022. Data encompass Company-sponsored, investigator-sponsored, and external collaboration studies. Abstracts to be shared at the meeting include data for the Company’s licensed medicines BAVENCIO® (avelumab), TEPMETKO® (tepotinib) and ERBITUX® (cetuximab), and its oncology pipeline. The presentations span key tumor types including advanced urothelial carcinoma (UC), advanced renal cell carcinoma (RCC), metastatic non-small cell lung cancer (NSCLC), metastatic colorectal cancer (CRC), and head and neck cancer (SCCHN). “We look forward to coming together with the scientific community at ASCO 2022, where we will share the latest data from our portfolio, which demonstrate our determination to make a real difference in the lives of